Seneste forsøg


EudraCT Number: 2006-002335-24 Sponsor Protocol Number: 13362B Start Date: 2006-11-23
Sponsor Name: University of Chicago
Full Title: A Phase III Randomized Trial of Docetaxel Based Induction Chemotherapy in Patients with N2/N3 Locally Advanced Head and Neck Cancer Estudio de fase III randomizado de una quimioterapia de inducción...
Medical condition: Phase III trial of induction therapy with docetaxel followed by chemoradiotherapy versus chemoradiotherapy alone in patients with nodal stage N2 or N3 head and neck cancer
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: ES (Ongoing)
Trial results: (No results available)

EudraCT Number: 2006-005494-21 Sponsor Protocol Number: MARIA Start Date: 2006-11-23
Sponsor Name: HYKS Marian sairaala
Full Title: Hyperbaarisen artikaiini-glukoosiliuoksen ja pelkän artikaiinin vertailu spinaalipuudutuksessa nivustyräpotilailla
Medical condition: nivustyrä
Disease: Version SOC Term Classification Code Term Level
8.1 10019909 Hernia LLT
Population Age: Adults Gender: Male, Female
Trial protocol: FI (Completed)
Trial results: (No results available)
EudraCT Number: 2006-005127-42 Sponsor Protocol Number: APIDR_L_01896 Start Date: 2006-11-22
Sponsor Name: Institut für Klinische Forschung und Entwicklung (ikfe) GmbH
Full Title: Effect of Prandial Treatment with Insulin Glulisine compared to Regular Human Insulin on Postprandial Endothelial Function and Microvascular Stress in Type 2 Diabetic Patients
Medical condition: Diabetes mellitus Type 2
Disease: Version SOC Term Classification Code Term Level
8.1 10012601 Diabetes mellitus LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: (No results available)

EudraCT Number: 2005-003632-22 Sponsor Protocol Number: WA19078 Start Date: 2006-11-22
Sponsor Name: F. Hoffmann-La Roche Ltd.
Full Title: An open-label, exploratory study of the pharmacokinetic and pharmacodynamic activity of rituximab in combination with methotrexate (MTX) in synovial tissue and in peripheral blood of patients with ...
Medical condition: Rheumatoid arthritis
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: ES (Completed)
Trial results: View results
EudraCT Number: 2006-002679-42 Sponsor Protocol Number: SNT-II-003 Start Date: 2006-11-22
Sponsor Name: Santhera Pharmaceuticals (Switzerland) Limited
Full Title: A double blind, randomised, placebo-controlled study of the efficacy, safety and tolerability of idebenone in the treatment of patients with Leber's Hereditary Optic Neuropathy
Medical condition: Leber's Hereditary Optic Neuropathy
Disease: Version SOC Term Classification Code Term Level
Population Age: Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: GB (Completed) DE (Completed)
Trial results: View results

EudraCT Number: 2006-000679-14 Sponsor Protocol Number: Mio/Reg/percutáneo/Aleatorizado Start Date: 2006-11-22
Sponsor Name: INSTITUTO CIENTÍFICO Y TECNOLÓGICO (ICT )DE NAVARRA, S.A.
Full Title: ESTUDIO DE FASE II CIEGO, CONTROLADO Y ALEATORIZADO DE EFICACIA DEL IMPLANTE PERCUTÁNEO DE MIOBLASTOS AUTÓLOGOS EN PACIENTES CON INFARTO ANTIGUO. (STUDY PHASE II BLINDED, CONTROLATED AND RANDOMIZED...
Medical condition: PACIENTES CON INFARTO ANTIGUO DE MIOCARDIO (PATIENTS WITH OLD MYOCARDIAL INFARCT)
Disease: Version SOC Term Classification Code Term Level
6.1 10052475 PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: ES (Completed)
Trial results: View results
EudraCT Number: 2006-003984-30 Sponsor Protocol Number: CASM981N2203S Start Date: 2006-11-22
Sponsor Name: Novartis Pharma Services AG
Full Title: A multicenter, randomized, double-blind, two-arm, vehicle-controlled, parallel-group, two stage study to evaluate and demonstrate the efficacy and to evaluate the safety of pimecrolimus 1% cream in...
Medical condition: Seborrhoeic Dermatitis (SD)
Disease: Version SOC Term Classification Code Term Level
8.1 10039793 Seborrhoeic dermatitis LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results

EudraCT Number: 2006-001839-21 Sponsor Protocol Number: LAP106988 / CHERLOB Start Date: 2006-11-22
Sponsor Name: GLAXO SMITH KLINE
Full Title: CHEMOTHERAPY PLUS LAPATINIB OR TRASTUZUMAB OR BOTH IN HER2 PRIMARY BREAST CANCER. A RANDOMIZED PHASE IIb STUDY WITH BIOMARKER EVALUATION.
Medical condition: MALIGNANT NEOPLASM FEMALE BREAST
Disease: Version SOC Term Classification Code Term Level
6.1 10057654 PT
Population Age: Adults, Elderly Gender: Female
Trial protocol: IT (Completed) GB (Completed) DE (Completed)
Trial results: View results
EudraCT Number: 2006-005842-35 Sponsor Protocol Number: FARM59T23W Start Date: 2006-11-22
Sponsor Name: Dipartimento di Pediatria Universita` di Napoli Federico II
Full Title: Efficacy and safety of treatment with N-butyl-deoxynojirimycin (NB-DNJ-miglustat) in patients with Niemann-Pick disease type C.
Medical condition: NIEMANN-PICK DISEASE TYPE C
Disease: Version SOC Term Classification Code Term Level
9.1 10029403 LLT
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: IT (Ongoing)
Trial results: (No results available)

EudraCT Number: 2006-001990-32 Sponsor Protocol Number: NOV002-C301 Start Date: 2006-11-22
Sponsor Name: NOVELOS THERAPEUTICS INC.
Full Title: A Randomized, Open-Label, Phase 3 Trial of NOV-002 in Combination with Paclitaxel and Carboplatin vs. Paclitaxel and Carboplatin Alone for the Treatment of Advanced Non-Small-Cell Lung Cancer (NS...
Medical condition: Patients with advanced NSCLC
Disease: Version SOC Term Classification Code Term Level
9.1 10029521 Non-small cell lung cancer stage IIIB LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Completed) GB (Completed)
Trial results: (No results available)
3
Abonner